Euretos

Enabling world leading pharma, biotech and academic institutions

Euretos

Mission

Transforming disease and drug research

We collaborate with our clients to unravel the complexities of human disease biology, reducing the risk and cost of therapy development. We generate data-driven disease insights through a unique combination of AI-driven, computational disease models, translational biology consultancy and direct access to the Euretos AI platform. This empowers scientists to draw their own, evidence based, conclusions and take a data-driven approach to disease research and drug discovery.

Euretos

Disease Modelling

AI-driven computational disease models

Euretos has created AI-driven computational disease models that have been tried and tested with many leading pharma and biotech companies. The disease models predict novel target-indication combinations by assessing whether a target’s biological interactors are linked to known disease associations. Domain experts can then review these predictions independently in the Euretos AI Platform and draw evidence based conclusions.

Find out More

Euretos

Knowledge Base

The world's largest AI-integrated knowledge base

We use AI to recognise and connect relevant information for molecular disease and drug research. Information from hundreds of life sciences databases and millions of publications and patents is harmonised and integrated using machine reading.

Find out More

The Cloud platform for target & disease research

Use the Euretos AI Platform to assess key target and disease aspects such as multi-omics interactions, gene expression in tissues, cell types and tumors, pathway interactions, regulatory and signalling responses, gene variants, clinical trials, target tractability and patents.

Find out More

Search - Optimised for disease and drug biology

Analytics - Systems biological multi-omics insights

Knowledge Graph - Biomolecular interaction analysis

Workflows - Target discovery & assessment (and more)

Enabling world leading pharma, biotech and academic institutions

Client review

Indication Selection

"“In this project we evaluated you against our internal investigations and the results of one other external provider. What really sets you apart is how you combine a fundamentally biological and data driven approach. The breadth of the indications you assess and the depth of your analysis sets you apart and is a clear value add to our internal capabilities.” "

Global Head Large European Pharma

Client review

Target Discovery

"“We worked with Euretos to leverage their AI capabilities with the aim of finding new targets in two different indications. It was a real pleasure to work with them and the whole process was characterized by transparency, their willingness to listen to our needs and suggestions, and swift responses and data delivery. In addition, we found their platform very useful for getting an overview of the different targets and for general inquiries.“"

Tau Benned-Jensen Senior Research Scientist, H. Lundbeck A/S

Client review

Target Assessment

""We are fascinated by the suggested hypothesis. It was great that even very small expressional changes were captured and a hypothesis was generated. The interpretation was also convincing and consistent. Also the team is well engaged, and had a very good understanding in the background of the project and our research question""

Principal Scientist Large Japanese Pharma

Client review

Euretos AI Platform

"I find the Euretos platform to be valuable in what it offers in terms of advanced AI capabilities and analytics of smart scouting and literature searches to probe relevant targets, indications, and therapeutics. The professional support and dedicated mentoring from experienced bioinformatics professionals that Euretos offers greatly enhances our ability to take advantage of all the capabilities of the platform, and extract meaningful insights for our day to day mission of bringing innovation into Teva."

Dr. Dana Bar-On Sr. Director, Head of Academic Affairs and Networks, Specialty R&D, Teva Pharmaceuticals

Client review

Target Discovery

"We have been working with Euretos for many years now. They provide us with unique tools that we use as an integral part of our target discovery and validation. Using the Euretos AI platform is a mandatory input to our target evaluation meetings."

Associate Director Target Discovery Large European Biotech

Client review

Indication Selection

"We find that the Euretos group was very easy to work with and communicate with. The professional staff at Euretos did a great job extending their bioinformatics platform and capabilities to our advantage. Euretos helped us to extract meaningful information from a highly complex data domain, that we could build on internally."

Henriette Husum Bak-Jensen Project Manager, Projects & Portfolio department, H. Lundbeck A/S

Projects

We work closely together with many pharmaceutical & biotech companies, especially in target discovery and indication selection. We generate data-driven disease insights through a unique combination of AI-driven, computational disease models, translational biology consultancy and direct access by our client's domain experts to the Euretos AI platform.

Target Discovery

Discover and evaluate novel targets for your disease of interest by the unique combination of Euretos molecular disease models and direct access to the Euretos AI Platform.

Indication Selection

Discover and evaluate novel indications for your target of interest by the unique combination of Euretos molecular disease models and direct access to the Euretos AI Platform.

Data-driven insights for disease research and drug discovery

The Cloud platform for target & disease research

Euretos Newsletter

Indication Selection

Target Discovery

Target Assessment

Euretos AI Platform

Target Discovery

Indication Selection

Projects

Target Discovery

Indication Selection

Transforming Disease and Drug Research

Subscribe to our Newsletter

Resources

Follow us